Irene Rozet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Irene Rozet has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Arthur M. Lam
5 shared publicationsMonica S. Vavilala
University of Washington and Harborview Injury Prevention and Research Center, Harborview Medical Center
4 shared publicationsLorri A. Lee
3 shared publicationsMiriam M. Treggiari
2 shared publications- Monica Shanta Vavilala
University of Washington, Seattle, Washington
2 shared publications Nuj Tontisirin
2 shared publications
Latest Publications
- 1 April 2016
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 60 (2) , 89-90
Dexmedetomidine Does Not Affect Evoked Potentials During Spine Surgery
- 1 April 2016
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 60 (2) , 89-90
Dexmedetomidine Does Not Affect Evoked Potentials During Spine Surgery
- 14 November 2011
- Published by Springer Nature
- p. 151-157
Positioning the Patient for Neurosurgical Operations
- 14 November 2011
- Published by Springer Nature
- p. 151-157
Positioning the Patient for Neurosurgical Operations
- 1 October 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 109 (4) , 1105-1110
Prolonged Propofol Anesthesia Is Not Associated with an Increase in Blood Lactate
Lactic acidosis is considered an early sign of propofol infusion syndrome. In this study, we investigated the changes in lactate and pH with propofol versus volatile anesthesia (VA) of long duration. Demographic and intraoperative data were recorded retrospectively from the anesthesia records of patients who underwent elective spine surgery longer than 8 h. Propofol patients were matched 1:2 to VA patients, based on anesthesia time (AT) (+/-30 min) and blood loss (BL) (+/-500 mL). Of 246 patients identified, 50 received propofol (AT = 10 +/- 2 h, BL = 1955 +/- 1409 mL) and were matched to 100 VA cases (AT = 10 +/- 1 h, BL = 1801 +/- 1543 mL), and of those, 40 and 72 patients, respectively, had complete lactate data at baseline and at 8 h after anesthesia and were included in the main analysis. The propofol group received 8.8 +/- 2 mg x kg(-1) x h(-1) of propofol. The VA group age was older than the propofol group (58 +/- 12 vs 51 +/- 15 yr, respectively, P = 0.002), but there was no difference between the groups in gender, ASA grade, intraoperative hemodynamic variables, and use of vasopressors. After 8 h, the VA group had a larger increase in arterial lactate from baseline compared with the propofol group (change from baseline: propofol, 0.48 +/- 0.72 mmol/L; VA, 1.2 +/- 1.2 mmol/L, P = 0.001). During prolonged spine surgery >8 h, VA was associated with higher serum lactate, when compared with propofol infusion. Prospective studies are needed to elucidate the exact mechanisms and clinical implications of this finding.
- 1 October 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 109 (4) , 1105-1110
Prolonged Propofol Anesthesia Is Not Associated with an Increase in Blood Lactate
Lactic acidosis is considered an early sign of propofol infusion syndrome. In this study, we investigated the changes in lactate and pH with propofol versus volatile anesthesia (VA) of long duration. Demographic and intraoperative data were recorded retrospectively from the anesthesia records of patients who underwent elective spine surgery longer than 8 h. Propofol patients were matched 1:2 to VA patients, based on anesthesia time (AT) (+/-30 min) and blood loss (BL) (+/-500 mL). Of 246 patients identified, 50 received propofol (AT = 10 +/- 2 h, BL = 1955 +/- 1409 mL) and were matched to 100 VA cases (AT = 10 +/- 1 h, BL = 1801 +/- 1543 mL), and of those, 40 and 72 patients, respectively, had complete lactate data at baseline and at 8 h after anesthesia and were included in the main analysis. The propofol group received 8.8 +/- 2 mg x kg(-1) x h(-1) of propofol. The VA group age was older than the propofol group (58 +/- 12 vs 51 +/- 15 yr, respectively, P = 0.002), but there was no difference between the groups in gender, ASA grade, intraoperative hemodynamic variables, and use of vasopressors. After 8 h, the VA group had a larger increase in arterial lactate from baseline compared with the propofol group (change from baseline: propofol, 0.48 +/- 0.72 mmol/L; VA, 1.2 +/- 1.2 mmol/L, P = 0.001). During prolonged spine surgery >8 h, VA was associated with higher serum lactate, when compared with propofol infusion. Prospective studies are needed to elucidate the exact mechanisms and clinical implications of this finding.
- 1 April 2009
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 21 (2) , 183-184
Report of the 36th Annual Meeting of Society of Neurosurgical Anesthesia and Critical Care
- 1 April 2009
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 21 (2) , 183-184
Report of the 36th Annual Meeting of Society of Neurosurgical Anesthesia and Critical Care
- 1 October 2008
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 21 (5) , 537-543
Anesthesia for functional neurosurgery: the role of dexmedetomidine
The purpose of this review is to summarize current approaches to the anesthetic management of functional neurosurgery and to describe the application of an α-2-adrenergic agonist dexmedetomidine in the anesthetic management of functional neurosurgical procedures. Dexmedetomidine, an α-2-adrenergic agonist, causes a unique kind of sedation, acting on the subcortical areas, which resembles natural sleep without respiratory depression. Experimental data demonstrate both cerebral vasoconstriction and vasodilatation, depending on the model and dose studied. At the clinically relevant doses, dexmedetomidine decreases cerebral blood flow and cerebral metabolic rate of oxygen in healthy volunteers. Clinical experience of dexmedetomidine use in functional neurosurgery is limited to small case-series. Nevertheless, these reports indicate that use of dexmedetomidine does not interfere with electrophysiologic monitoring, thus allowing brain mapping during awake craniotomy and microelectrode recording during implantation of deep-brain stimulators. Dexmedetomidine has been demonstrated to provide a successful sedation without impairment of electrophysiologic monitoring in functional neurosurgery. Prospective randomized studies are warranted to delineate an optimal regimen of dexmedetomidine sedation and any dose-related influence on neurophysiologic function.
- 1 October 2008
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 21 (5) , 537-543
Anesthesia for functional neurosurgery: the role of dexmedetomidine
The purpose of this review is to summarize current approaches to the anesthetic management of functional neurosurgery and to describe the application of an α-2-adrenergic agonist dexmedetomidine in the anesthetic management of functional neurosurgical procedures. Dexmedetomidine, an α-2-adrenergic agonist, causes a unique kind of sedation, acting on the subcortical areas, which resembles natural sleep without respiratory depression. Experimental data demonstrate both cerebral vasoconstriction and vasodilatation, depending on the model and dose studied. At the clinically relevant doses, dexmedetomidine decreases cerebral blood flow and cerebral metabolic rate of oxygen in healthy volunteers. Clinical experience of dexmedetomidine use in functional neurosurgery is limited to small case-series. Nevertheless, these reports indicate that use of dexmedetomidine does not interfere with electrophysiologic monitoring, thus allowing brain mapping during awake craniotomy and microelectrode recording during implantation of deep-brain stimulators. Dexmedetomidine has been demonstrated to provide a successful sedation without impairment of electrophysiologic monitoring in functional neurosurgery. Prospective randomized studies are warranted to delineate an optimal regimen of dexmedetomidine sedation and any dose-related influence on neurophysiologic function.
- 1 April 2008
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 20 (2) , 137-139
Methylprednisolone in Acute Spinal Cord Injury
- 1 April 2008
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 20 (2) , 137-139
Methylprednisolone in Acute Spinal Cord Injury
- 1 February 2008
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 108 (2) , 330
Propofol Infusion Syndrome or Probable Overinterpretation Syndrome?
It was with great interest that we read the article by Cravens et al. 1 on the incidence of propofol infusion syndrome. This is obviously an important question with significant clinical relevance. However, with all of the inherent limitations of a retrospective study as recognized by the authors, we find the interpretation and conclusion of the authors (“this study provides evidence that even in a non–critically ill population, prolonged high-dose propofol infusion is associated with otherwise unexplained metabolic acidosis in a significant number of patients”) to be inconsistent with the limited data presented.
- 1 February 2008
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 108 (2) , 330
Propofol Infusion Syndrome or Probable Overinterpretation Syndrome?
It was with great interest that we read the article by Cravens et al. 1 on the incidence of propofol infusion syndrome. This is obviously an important question with significant clinical relevance. However, with all of the inherent limitations of a retrospective study as recognized by the authors, we find the interpretation and conclusion of the authors (“this study provides evidence that even in a non–critically ill population, prolonged high-dose propofol infusion is associated with otherwise unexplained metabolic acidosis in a significant number of patients”) to be inconsistent with the limited data presented.
- 1 December 2007
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 21 (4) , 465-482
Respiratory care
- 1 December 2007
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 21 (4) , 465-482
Respiratory care
- 1 November 2007
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 107 (5) , 697-704
Effect of Equiosmolar Solutions of Mannitol versus Hypertonic Saline on Intraoperative Brain Relaxation and Electrolyte Balance
Background: The purpose of the study was to compare the effect of equiosmolar solutions of mannitol and hypertonic saline (HS) on brain relaxation and electrolyte balance. Methods: After institutional review board approval and informed consent, patients with American Society of Anesthesiologists physical status II-IV, scheduled to undergo craniotomy for various brain pathologies, were enrolled into this prospective, randomized, double-blind study. Patients received 5 ml/kg 20% mannitol (n = 20) or 3% HS (n = 20). Partial pressure of carbon dioxide in arterial blood was maintained at 35-40 mmHg, and central venous pressure was maintained at 5 mmHg or greater. Hemodynamic variables, fluid balance, blood gases, electrolytes, lactate, and osmolality (blood, cerebrospinal fluid, urine) were measured at 0, 15, 30, and 60 min and 6 h after infusion; arteriovenous difference of oxygen, glucose, and lactate were calculated. The surgeon assessed brain relaxation on a four-point scale (1 = relaxed, 2 = satisfactory, 3 = firm, 4 = bulging). Appropriate statistical tests were used for comparison; P < 0.05 was considered significant. Results: There was no difference in brain relaxation (mannitol = 2, HS = 2 points; P = 0.8) or cerebral arteriovenous oxygen and lactate difference between HS and mannitol groups. Urine output with mannitol was higher than with HS (P < 0.03) and was associated with higher blood lactate over time (P < 0.001, compared with HS). Cerebrospinal fluid osmolality increased at 6 h in both groups (P < 0.05, compared with baseline). HS caused an increase in sodium in cerebrospinal fluid over time (P < 0.001, compared with mannitol). Conclusion: Mannitol and HS cause an increase in cerebrospinal fluid osmolality, and are associated with similar brain relaxation scores and arteriovenous oxygen and lactate difference during craniotomy.
- 1 November 2007
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 107 (5) , 697-704
Effect of Equiosmolar Solutions of Mannitol versus Hypertonic Saline on Intraoperative Brain Relaxation and Electrolyte Balance
Background: The purpose of the study was to compare the effect of equiosmolar solutions of mannitol and hypertonic saline (HS) on brain relaxation and electrolyte balance. Methods: After institutional review board approval and informed consent, patients with American Society of Anesthesiologists physical status II-IV, scheduled to undergo craniotomy for various brain pathologies, were enrolled into this prospective, randomized, double-blind study. Patients received 5 ml/kg 20% mannitol (n = 20) or 3% HS (n = 20). Partial pressure of carbon dioxide in arterial blood was maintained at 35-40 mmHg, and central venous pressure was maintained at 5 mmHg or greater. Hemodynamic variables, fluid balance, blood gases, electrolytes, lactate, and osmolality (blood, cerebrospinal fluid, urine) were measured at 0, 15, 30, and 60 min and 6 h after infusion; arteriovenous difference of oxygen, glucose, and lactate were calculated. The surgeon assessed brain relaxation on a four-point scale (1 = relaxed, 2 = satisfactory, 3 = firm, 4 = bulging). Appropriate statistical tests were used for comparison; P < 0.05 was considered significant. Results: There was no difference in brain relaxation (mannitol = 2, HS = 2 points; P = 0.8) or cerebral arteriovenous oxygen and lactate difference between HS and mannitol groups. Urine output with mannitol was higher than with HS (P < 0.03) and was associated with higher blood lactate over time (P < 0.001, compared with HS). Cerebrospinal fluid osmolality increased at 6 h in both groups (P < 0.05, compared with baseline). HS caused an increase in sodium in cerebrospinal fluid over time (P < 0.001, compared with mannitol). Conclusion: Mannitol and HS cause an increase in cerebrospinal fluid osmolality, and are associated with similar brain relaxation scores and arteriovenous oxygen and lactate difference during craniotomy.
- 1 September 2007
- Published by Elsevier in Anesthesiology Clinics
- Vol. 25 (3) , 631-653
Risks and Benefits of Patient Positioning During Neurosurgical Care
- 1 September 2007
- Published by Elsevier in Anesthesiology Clinics
- Vol. 25 (3) , 631-653
Risks and Benefits of Patient Positioning During Neurosurgical Care